What We're Reading: Page 306
Industry reads hand-picked by our editors
Mar 15, 2017
-
Kaiser Health News
By the numbers: Trump’s choice for FDA chief is versatile, entrenched in pharma
-
The Guardian
New GlaxoSmithKline chief to earn 25% less than her predecessor
-
Forbes
Here's how pharma is using AI deep learning to cure aging
-
Scientific American
Treating epilepsy’s toughest cases
Mar 14, 2017
-
The New York Times
Bernie Sanders: Trump should avoid a bad Zika deal
-
Los Angeles Times
Dying patients want easier access to experimental drugs. Here's why experts say that's bad medicine
-
Crain's New York
Mayor blasts big pharma for overdose crisis
-
The Washington Post
Lloyd Conover, chemist who revolutionized antibiotics, dies at 93
Mar 13, 2017
-
Bloomberg Gadfly
Trump is losing his ability to scare biotech
-
The Economist
A digital revolution in health care is speeding up
-
The New York Times
2 of a farmer's 3 children overdosed. What of the third - and the land?
-
Financial Times
Sanofi hails broader promise of eczema medicine
Mar 10, 2017
-
Reuters
As biosimilars hit, EU pharma warns against blanket prescribing
-
Science
Data check: U.S. government share of basic research funding falls below 50%
-
The New York Times
As rebels move out of Colombia drug trade, corporations look to move in
-
The Washington Post
NFL abuse of painkillers and other drugs described in court filings
-
MedCity News
A rockstar, big pharma and an advocacy group unite
Previous
